Other medical trials in patients with non-Hodgkin's lymphoma [24] and sufferers with State-of-the-art malignancy [14] have proven also that zosuquidar didn't drastically impact the pharmacokinetics of doxorubicin and experienced average results to the pharmacokinetics of vincristine. These clinical trials permitted that zosuquidar could safely administrated with daunorubicin, doxorubi... https://parishin32108.theideasblog.com/28498238/the-single-best-strategy-to-use-for-imdk